|
Bisphosphonate Conjugates with RON Kinase Inhibitors
Researchers at TGen and the University of Utah are developing bisphosphonate (diphosphonic acid) conjugates with RON kinase inhibitor compounds for treating metastatic cancers, such as breast cancer, and diseases, such as osteoporosis and osteoarthritis, associated with bone destruction. These conjugated bisphosphonates combine the anti-mitotic, anti-angiogenic,...
Published: 4/10/2024
|
Inventor(s): Hariprasad Vankayalapati, Sunil Sharma, Alana Welm
Keywords(s):
Category(s): Therapeutics, Chemicals, Biotechnology
|
